ESRRA and diabetic kidney disease: This restoration was corroborated in vivo studies, where AAV‐mediated introduction of ERRα with a mutated K100 residue (ERRαK100R) significantly improved renal function and attenuated mitochondrial damage in DKD models, as evidenced by histological and biochemical analyses (Figure S10A–I, Supporting Information).